✦ LIBER ✦

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension

✍ Scribed by Jan A Staessen; Robert Fagard; Lutgarde Thijs; Hilde Celis; Guramy G Arabidze; Willem H Birkenhäger; Christopher J Bulpitt; Peter W de Leeuw; Colin T Dollery; Astrid E Fletcher; Françoise Forette; Gastone Leonetti; Choudomir Nachev; Eoin T O' Brien; Joseph Rosenfeld; José L Rodicio; Jaakko Tuomilehto; Alberto Zanchetti

Book ID: 118562330
Publisher: The Lancet
Year: 1997
Tongue: English
Weight: 108 KB
Volume: 350
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(97)05381-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomised, placebo-controlled, double

A randomised, placebo-controlled, double-blind, crossover study of losartan and enalapril in patients with essential hypertension

✍ Fagard, R; Lijnen, P; Pardaens, K; Thijs, L; Vinck, W 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 142 KB

A randomized, double-blind, active-contr

A randomized, double-blind, active-controlled, parallel-group comparison of valsartan and amlodipine in the treatment of isolated systolic hypertension in elderly patients: The Val-Syst study

✍ Ettore Malacco; Natale Vari; Vincenzo Capuano; Vitaliano Spagnuolo; Carlo Borgni 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 102 KB

Treatment with aliskiren/amlodipine comb

Treatment with aliskiren/amlodipine combination in patients with moderate-to-severe hypertension: a randomised, double-blind, active comparator trial

✍ R. C. Braun-Dullaeus; S. B. Shustov; C. Alvarez; G. G. Rogelio; J. Zhang; S. Hri 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 253 KB

Ivabradine for patients with stable coro

Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial

✍ Kim Fox; Ian Ford; P Gabriel Steg; Michal Tendera; Roberto Ferrari 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 285 KB

Norfloxacin treatment for clinically sig

Norfloxacin treatment for clinically significant portal hypertension: results of a randomised double-blind placebo-controlled crossover trial

✍ William Kemp; John Colman; Kenneth Thompson; Anoop Madan; Margaret Vincent; Jaye 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 176 KB

Once-daily eprosartan mesylate in the tr

Once-daily eprosartan mesylate in the treatment of elderly patients with isolated systolic hypertension: data from a 13-week double-blind, placebo-controlled, parallel, multicenter study

✍ Punzi, H A; Punzi, C F 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 230 KB